Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessCorrection

Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice

Christina A Pacak* email, Yoshihisa Sakai* email, Bijoy D Thattaliyath email, Cathryn S Mah email and Barry J Byrne email

Powell Gene Therapy Center, College of Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610-0266, USA

author email corresponding author email* Contributed equally

Genetic Vaccines and Therapy 2009, 7:3doi:10.1186/1479-0556-7-3

The electronic version of this article is the complete one and can be found online at: http://www.gvt-journal.com/content/7/1/3

Received: 28 January 2009
Accepted: 4 February 2009
Published: 4 February 2009

© 2009 Pacak et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Correction

Since publication of our article [1], it has come to our attention that the alpha-myosin heavy chain promoter was incorrectly identified as being of human origin. The correct origin of the promoter was from mouse.

The corrections within the text are as follows:

Under the heading Findings, 5 paragraph, line 3: "human alpha-myosin heavy chain" should be "murine alpha-myosin heavy chain."

Under the heading Findings, 8th paragraph, line 1: "The human a-MHC promoter" should be "The murine a-MHC promoter"

Figure 1, Figure legend, line 6; "...created by amplifying human genomic DNA" should be "... created by amplifying mouse genomic DNA."

The authors regret the error and any inconveniences to the readers. The results and conclusions of this article remain unchanged.

References

  1. Pacak CA, Sakai Y, Thattaliyath BD, Mah CS, Byrne BJ: Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice.

    Genetic Vaccines and Therapy 2008, 6:13. BioMed Central Full Text OpenURL

Have something to say? Post a comment on this article!


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.